| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 06/14/2001 | US20010003752 Crystalline form of 4- [ 5-methyl-3-phenylisoxazol-4-yl ] benzenesulfonamide |
| 06/14/2001 | CA2733434A1 Caspase inhibitors and uses thereof |
| 06/14/2001 | CA2396739A1 Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis |
| 06/14/2001 | CA2394917A1 Polypeptides and polynucleotides encoding same |
| 06/14/2001 | CA2394891A1 Substituted phthalocyanines and their precursors |
| 06/14/2001 | CA2394303A1 Interferon-alpha induced gene |
| 06/14/2001 | CA2394236A1 Adamantane derivatives |
| 06/14/2001 | CA2393779A1 Combination of compounds that inhibit the biological effects of tnf-.alpha. and cd95l in a medicament |
| 06/14/2001 | CA2393661A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2393532A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2393463A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 06/14/2001 | CA2392961A1 G-protein coupled receptors |
| 06/14/2001 | CA2392740A1 Il-6 like polynucleotides, polypeptides, and antibodies |
| 06/14/2001 | CA2392584A1 Substituted pyridazines having cytokine inhibitory activity |
| 06/14/2001 | CA2392566A1 4-pyridinyl-n-acyl-l-phenylalanines |
| 06/14/2001 | CA2388686A1 Vla-4 integrin antagonists |
| 06/14/2001 | CA2362815A1 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 06/14/2001 | CA2362675A1 Polymorphic crystalline forms of celecoxib |
| 06/13/2001 | EP1106615A1 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/13/2001 | EP1106614A1 5-Membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/13/2001 | EP1105477A1 Dcr5, a bmp-binding protein, and applications thereof |
| 06/13/2001 | EP1105467A1 USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES |
| 06/13/2001 | EP1105414A2 Synthetic peptides and methods of use for autoimmune disease therapies |
| 06/13/2001 | EP1105389A1 Integrin receptor antagonists |
| 06/13/2001 | EP1105384A1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors |
| 06/13/2001 | EP1105371A2 Novel aryl sulphonamide amino acid esters and analogues |
| 06/13/2001 | EP1105370A1 Novel aryl sulphonamides and analogues |
| 06/13/2001 | EP1105143A1 Human histone deacetylase gene hd4 |
| 06/13/2001 | EP1105109A1 Injectable formulations of nanoparticulate naproxen |
| 06/13/2001 | EP1105104A1 Extended release buccal bioadhesive tablet |
| 06/13/2001 | EP0927029A4 Novel methods |
| 06/13/2001 | EP0651765B1 Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis |
| 06/13/2001 | CN1299407A Vascular endothelial growth factor 2 |
| 06/13/2001 | CN1299357A Indole derivatives useful A.O. for the treatment of osteoporosis |
| 06/13/2001 | CN1299282A Vitronectin receptor antagonists |
| 06/13/2001 | CN1299281A Use of oxazolidinone derivative for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy |
| 06/13/2001 | CN1298881A Solid, stable and concentrated type ortho-silicis acid complex based on bio-absorption, and its prepn. method |
| 06/13/2001 | CN1298735A Musk plaster for bone-set |
| 06/13/2001 | CN1298727A Plaster for treating hyperosteogeny |
| 06/13/2001 | CN1298717A Process for preparing Tibetan medicines |
| 06/13/2001 | CN1298712A Plaster for treating arthritis, injury, mastitis, sore and furuncle and its preparing process |
| 06/13/2001 | CN1298710A Process for preparing exterior-applied plaster |
| 06/13/2001 | CN1067065C (-)cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate |
| 06/12/2001 | US6245896 A polypeptide; diagnosis and therapy of endometriosis, antitumor/antiproliferative/anticarcinogenic agents; enhancing in situ fertilization |
| 06/12/2001 | US6245801 Branched alkyl pyrrolidine-3-carboxylic acids |
| 06/12/2001 | US6245790 Oxazole compounds useful as PGE2 agonists and antagonists |
| 06/12/2001 | US6245760 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 06/12/2001 | US6245759 Tyrosine kinase inhibitors |
| 06/12/2001 | US6245332 Modulation of systemic memory T cell trafficking |
| 06/11/2001 | WO2001044230A1 1-(aminophenyl)-2-pyrrolidones as integrin inhibitors |
| 06/11/2001 | CA2393310A1 1-(aminophenyl)-2-pyrrolidones as integrin inhibitors |
| 06/10/2001 | CA2327946A1 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/10/2001 | CA2327925A1 5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/07/2001 | WO2001040521A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 06/07/2001 | WO2001040513A2 Method of diagnosing rheumatoid arthritis and method of treating rheumatoid arthritis |
| 06/07/2001 | WO2001040253A2 3-methylene steroid derivative for the treatment of autoimmune diseases |
| 06/07/2001 | WO2001040231A1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 06/07/2001 | WO2001040230A1 Pyrazolopyrazines and their use as adenosine antagonists |
| 06/07/2001 | WO2001040217A1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 06/07/2001 | WO2001040216A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | WO2001040215A1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 06/07/2001 | WO2001040201A1 Oxazolidinone derivatives |
| 06/07/2001 | WO2001039812A1 A bioabsorbable drug delivery system |
| 06/07/2001 | WO2001039795A2 Attenuation of fibroblast proliferation |
| 06/07/2001 | WO2001039786A2 New uses of suppressive macrophage activation factors |
| 06/07/2001 | WO2001039724A2 Phosphonate compounds |
| 06/07/2001 | WO2001032865A8 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 06/07/2001 | WO2001015553B1 Dietary food supplement containing natural cyclooxygenase inhibitors |
| 06/07/2001 | WO2001007612A3 Receptors and associated proteins |
| 06/07/2001 | WO2000072823A8 Preparations for the application of anti-inflammatory agents |
| 06/07/2001 | US20010003121 Adamantane derivatives such as 2,4-dichloro-N-(tricyclo(3.3.1.13,7)dec-1-methyl)-benzamide; administering to treat rheumatoid arthritis; immunosuppressant |
| 06/07/2001 | US20010003002 As dietary supplement, for treating osteoporosis |
| 06/07/2001 | DE19958153A1 Oxazolidinon-Derivate Oxazolidinone derivatives |
| 06/07/2001 | CA2747954A1 Phosphonate compounds |
| 06/07/2001 | CA2393217A1 Oxazolidinone derivatives |
| 06/07/2001 | CA2393186A1 Attenuation of fibroblast proliferation |
| 06/07/2001 | CA2392948A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 06/07/2001 | CA2392931A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | CA2391551A1 Methods for diagnosis and therapy of rheumatoid arthritis |
| 06/07/2001 | CA2391096A1 3-methylene steroid derivatives |
| 06/07/2001 | CA2390786A1 Compositions and methods for the treatment of immune related diseases |
| 06/07/2001 | CA2390415A1 New uses of suppressive macrophage activation factors |
| 06/06/2001 | EP1104762A1 Substituted imidazo 1,2a]azines as selective inhibotors of cox-2 |
| 06/06/2001 | EP1104760A1 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104759A1 Heteroaryl phenyl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104758A1 Acetylene derivatives as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104465A1 14400 receptor, a g-protein coupled receptor |
| 06/06/2001 | EP1104440A1 A g-protein coupled 7tm receptor (axor-1) |
| 06/06/2001 | EP1104420A1 Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors |
| 06/06/2001 | EP1104412A1 Tace inhibitors |
| 06/06/2001 | EP1104411A1 Calcilytic compounds |
| 06/06/2001 | EP1104403A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 06/06/2001 | EP1104304A1 Multivalent avb3 and metastasis-associated receptor ligands |
| 06/06/2001 | CN2432938Y Anti-inflammatory and analgesic adhesive plaster |
| 06/06/2001 | CN1298404A Inhibitors of phospholipase A2 |
| 06/06/2001 | CN1297769A Orthopaedic and traumatological plaster |
| 06/06/2001 | CN1297764A Fast-acting trauma remedy |
| 06/06/2001 | CN1297757A Medicine liquid for treating pain of injury |
| 06/06/2001 | CN1297750A Medicine for treating rheumatism, rheumatoid disease and hyperosteogeny |
| 06/06/2001 | CN1297745A Medicine for treating fracture and traumatic injury |